<--- Back to Details
First PageDocument Content
Iron metabolism / Hepcidin / Human iron metabolism / Ferroportin / Transferrin / Iron deficiency / Anemia of chronic disease / Iron overload / Hephaestin / Ferritin / Acute-phase protein / Iron metabolism disorder
Date: 2015-05-04 08:54:02
Iron metabolism
Hepcidin
Human iron metabolism
Ferroportin
Transferrin
Iron deficiency
Anemia of chronic disease
Iron overload
Hephaestin
Ferritin
Acute-phase protein
Iron metabolism disorder

THE METABOLISM OF IRON IRON IO IONS Oral supply 5-25% availability

Add to Reading List

Source URL: www.ironatlas.com

Download Document from Source Website

File Size: 1,15 MB

Share Document on Facebook

Similar Documents

THE METABOLISM OF IRON IRON IO IONS Oral supply 5-25% availability

THE METABOLISM OF IRON IRON IO IONS Oral supply 5-25% availability

DocID: 1ptV5 - View Document

Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive a

Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive a

DocID: 1a5Tb - View Document

PRESS RELEASE  First Data from NOXXON’s NOX-H94 (Lexaptepid Pegol) Clinical Trial in ESA-Hyporesponsive Dialysis Patients Reported at ERA-EDTA Conference Berlin, Germany and Boston, USA - May 29, NOXXON Pharma a

PRESS RELEASE First Data from NOXXON’s NOX-H94 (Lexaptepid Pegol) Clinical Trial in ESA-Hyporesponsive Dialysis Patients Reported at ERA-EDTA Conference Berlin, Germany and Boston, USA - May 29, NOXXON Pharma a

DocID: 19ryN - View Document

PDF Document

DocID: 191Vu - View Document

LEAD Action News vol 9 no 3 Short Part 1

LEAD Action News vol 9 no 3 Short Part 1

DocID: 183Zb - View Document